Проблема периоперационного прогнозирования гнойных осложнений эндопротезирования тазобедренного и коленного суставов. Часть II (обзор литературы)

Проблема периоперационного прогнозирования гнойных осложнений эндопротезирования тазобедренного и коленного суставов. Часть II (обзор литературы)

Автор: Брагина Светлана Валентиновна, Москалв Валерий Петрович, Петрушин Александр Леонидович, Березин Павел Андреевич

Журнал: Гений ортопедии @geniy-ortopedii

Рубрика: Обзор литературы

Статья в выпуске: 4 т.28, 2022 года.

Бесплатный доступ

Введение. В попытке уменьшения риска развития гнойных осложнений артропластики тазобедренного и коленного суставов исследователи изучают возможности влияния на факторы риска в периоперационном периоде. Цель. Систематизация информации о потенциально модифицируемых факторах риска гнойных осложнений эндопротезирования тазобедренного и коленного суставов и возможностях влияния на них. Материалы и методы. Поиск литературных источников проводился в открытых электронных базах данных научной литературы PubMed, eLIBRARY, Scopus, Dimensions. Глубина поиска - 30 лет. Результаты. В обзоре проанализированы потенциально модифицируемые факторы риска и возможности влияния на них в периоперационном периоде. Часто пациенты с показаниями для эндопротезирования крупных суставов имеют коморбидную патологию, которую необходимо компенсировать на этапе подготовки к хирургическому вмешательству и в послеоперационном периоде. В том числе это может быть патология суставов: олиго-, полиостеоартроз, артропластика других суставов, септический артрит или перипротезная инфекция в анамнезе. Соматические заболевания нередко связаны с отклонением от нормы определенных лабораторных показателей. Все эти факторы риска не могут быть полностью устранены и расцениваются как неблагоприятный фон для проведения эндопротезирования тазобедренного и коленного суставов. Дискуссия. Современный уровень информации о возможных рисках развития гнойных осложнений артропластики тазобедренного и коленного суставов не всегда позволяет повлиять на снижение частоты возникновения инфекционных осложнений. Сохраняется неопределенность в отношении некоторых предикторов инфекции области хирургического вмешательства, перипротезной инфекции. Не всегда имеется однозначная причинно-следственная связь между потенциально неблагоприятным фоном пациента и негативным результатом операции, что требует дальнейшего углублённого изучения данной проблемы.

Еще

Эндопротезирование суставов, инфекция области хирургического вмешательства, перипротезная инфекция, прогнозирование, факторы риска

Короткий адрес: https://sciup.org/142235729

IDR: 142235729   |   DOI: 10.18019/1028-4427-2022-28-4-608-618

Список литературы Проблема периоперационного прогнозирования гнойных осложнений эндопротезирования тазобедренного и коленного суставов. Часть II (обзор литературы)

  • Возможности прогноза инфекционных осложнений хирургического вмешательства при эндопротезировании тазобедренного сустава / Ю.Л. Дорофеев, А.Ф. Калимуллина, Д.А. Пташников, С.А. Линник, А.Н. Ткаченко, О.С. Жаровских // Вестник экспериментальной и клинической хирургии. 2014. № 3. С. 269-278.
  • Marculescu C.E., Mabry T., Berbari E.F. Prevention of Surgical Site Infections in Joint Replacement Surgery // Surg. Infect. (Larchmt). 2016, Vol. 17, No 2. P. 152-157. DOI: 10.1089/sur.2015.258.
  • Periprosthetic Joint Infection in Patients with Inflammatory Joint Disease: Prevention and Diagnosis / A. Premkumar, K. Morse, A.E. Levack, M.P. Bostrom, A.V Carli // Curr. Rheumatol. Rep. 2018. Vol. 20, No 11. P. 68. DOI: 10.1007/s11926-018-0777-6.
  • Rezapoor M., Parvizi J. Prevention of Periprosthetic Joint Infection// J. Arthroplasty. 2015. Vol. 30, No 6. Р. 902-907. DOI: 10.1016/j.arth.2015.02.044.
  • Are we winning or losing the battle with periprosthetic joint infection: trends in periprosthetic joint infection and mortality risk for the Medicare population / S.M. Kurtz, E.C. Lau, M.S. Son, E.T. Chang, W. Zimmerli, J. Parvizi // J. Arthroplasty. 2018. Vol. 33, No 10. P. 3238-3245. DOI: 10.1016/j.arth.2018.05.042.
  • Лечение парапротезной инфекции коленного сустава / В.М. Прохоренко, А.В. Злобин, А.А. Мамедов, В.С. Баитов // Современные проблемы науки и образования. 2015. № 6. С. 118.
  • A retrieval analysis perspective on revision for infection / M.A. Kokko, M.P. Abdel, D.J. Berry, R.D. Butler, D.W. van Citters // Arthroplast. Today. 2019. Vol. 5, No 3. P. 362-370. DOI: 10.1016/j.artd.2019.03.007.
  • Adeli B., Parvizi J. Strategies for the prevention of periprosthetic joint infection // J. Bone Joint Surg. Br. 2012. Vol. 94, No 11 Suppl. A. Р. 42-46. DOI: 10.1302/0301-620X.94B11.30833.
  • Проблема периоперационного прогнозирования гнойных осложнений эндопротезирования тазобедренного и коленного суставов. Часть I (обзор литературы) / С.В. Брагина, В.П. Москалёв, А.Л. Петрушин, П.А. Березин // Гений ортопедии. 2021. Т. 27, No 5. С. 636-644. DOI: 10.18019/1028-4427-2021-27-5-636-644.
  • Patient-related risk factors for postoperative mortality and periprosthetic joint infection in Medicare patients undergoing TKA / K.J. Bozic, E. Lau, S. Kurtz, K. Ong, D.J. Berry // Clin. Orthop. Relat. Res. 2012. Vol. 470, No 1. P. 130-137. DOI: 10.1007/s11999-011-2043-3.
  • The influence of diabetes mellitus on the post-operative outcome of elective primary total knee replacement: a systematic review and meta-analysis / Z. Yang, H. Liu, X. Xie, Z. Tan, T. Qin, P. Kang // Bone Joint J. 2014. Vol. 96-B, No 12. Р. 1637-1643. DOI: 10.1302/0301-620X.96B12.34378.
  • Lee Q.J., Mak W.P., Wong Y.C. Risk factors for periprosthetic joint infection in total knee arthroplasty // J. Orthop. Surg. (Hong Kong). 2015. Vol. 23, No 3. P. 282-286. DOI: 10.1177/230949901502300303.
  • Long-term glycemic control and postoperative infectious complications / A.S. Dronge, M.F. Perkal, S. Kancir, J. Concato, M. Aslan, R.A. Rosenthal // Arch. Surg. 2006. Vol. 141, No 4. P. 375-380. DOI: 10.1001/archsurg.141.4.375.
  • Recurrent periprosthetic joint infection: persistent or new infection? / B. Zmistowski, M.W. Tetreault, P. Alijanipour, A.F. Chen, C.J. Della Valle, J. Parvizi // J. Arthroplasty. 2013. Vol. 28, No 9. P. 1486-1489. DOI: 10.1016/j.arth.2013.02.021.
  • Effect of culture media and nutrients on biofilm growth kinetics of laboratory and clinical strains of Enterococcus faecalis / C.J. Seneviratne, J.W. Yip, J.W. Chang, C.F. Zhang, L.P. Samaranayake // Arch. Oral Biol. 2013. Vol. 58, No 10. P. 1327-1334. DOI: 10.1016/j.archoralbio.2013.06.017.
  • Global estimates of diabetes prevalence for 2013 and projections for 2035 / L. Guariguata, D.R. Whiting, I. Hambleton, J. Beagley, U. Linnenkamp, J.E. Shaw // Diabetes Res. Clin. Pract. 2014. Vol. 103, No 2. P. 137-149. DOI: 10.1016/j.diabres.2013.11.002.
  • Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study / G. Schett, A. Kleyer, C. Perricone, E. Sahinbegovic, A. Iagnocco, J. Zwerina, R. Lorenzini, F. Aschenbrenner, F. Berenbaum, M.A. D'Agostino, J. Willeit, S. Kiechl // Diabetes Care. 2013. Vol. 36, No 2. P. 403-409. DOI: 10.2337/dc12-0924.
  • Obesity, diabetes, and preoperative hyperglycemia as predictors of periprosthetic joint infection: a single-center analysis of 7181 primary hip and knee replacements for osteoarthritis / E. Jamsen, P. Nevalainen, A. Eskelinen, K. Huotari, J. Kalliovalkama, T. Moilanen // J. Bone Joint Surg. Am. 2012. Vol. 94, No 14. P. e101. DOI: 10.2106/JBJS.J.01935.
  • The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty / M.H. Marchant Jr., N.A. Viens, C. Cook, T.P. Vail, M.P. Bolognesi // J. Bone Joint Surg. Am. 2009. Vol. 91, No 7. P. 1621-1629. DOI: 10.2106/JBJS.H.00116.
  • Risk factors for prosthetic joint infection: case-control study / E.F. Berbari, A.D. Hanssen, M.C. Duffy, J.M. Steckelberg, D.M. Ilstrup, W.S. Harmsen, D.R. Osmon // Clin. Infect. Dis. 1998. Vol. 27, No 5. P. 1247-1254. DOI: 10.1086/514991.
  • Patient-related risk factors for periprosthetic joint infection and postoperative mortality following total hip arthroplasty in Medicare patients / K.J. Bozic, E. Lau, S. Kurtz, K. Ong, H. Rubash, T.P. Vail, D.J. Berry // J. Bone Joint Surg. Am. 2012. Vol. 94, No 9. Р. 794-800. DOI: 10.2106/ JBJS.K.00072.
  • Risk of revision for infection in primary total hip and knee arthroplasty in patients with rheumatoid arthritis compared with osteoarthritis: a prospective, population-based study on 108,786 hip and knee joint arthroplasties from the Norwegian Arthroplasty Register / J.C. Schrama, B. Espehaug, G. Hallan, L.B. Engesaeter, O. Furnes, L.I. Havelin, B.T. Fevang // Arthritis Care Res. (Hoboken). 2010. Vol. 62, No 4. P. 473-479. DOI: 10.1002/acr.20036.
  • Tande A.J., Patel R. Prosthetic joint infection // Clin. Microbiol. Rev. 2014. Vol. 27, No 2. P. 302-345. DOI: 10.1128/CMR.00111-13.
  • Prosthetic joint infection after total hip or knee arthroplasty in rheumatoid arthritis patients treated with nonbiologic and biologic disease-modifying antirheumatic drugs / S. Momohara, K. Kawakami, T. Iwamoto, K. Yano, Y. Sakuma, R. Hiroshima, H. Imamura, I. Masuda, A. Tokita, K. Ikari // Mod. Rheumatol. 2011. Vol 21, No 5. P. 469-475. DOI: 10.1007/s10165-011-0423-x.
  • Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor-alpha blockers: perioperative interruption of tumour necrosis factor-alpha blockers decreases complications? / K. Kawakami, K. Ikari, K. Kawamura, S. Tsukahara, T. Iwamoto, K. Yano, Y. Sakuma, A. Tokita, S. Momohara // Rheumatology (Oxford). 2010. Vol. 49, No 2. P. 341-347. DOI: 10.1093/rheumatology/kep376.
  • White R.H., McCurdy S.A., Marder R.A. Early morbidity after total hip replacement: rheumatoid arthritis versus osteoarthritis // J. Gen. Intern. Med. 1990. Vol. 5, No 4. P. 304-309. DOI: 10.1007/BF02600396.
  • Local infectious complications following large joint replacement in rheumatoid arthritis patients treated with methotrexate versus those not treated with methotrexate / R.S. Perhala, W.S. Wilke, J.D. Clough, A.M. Segal // Arthritis Rheum. 1991. Vol. 34, No 2. P. 146-152. DOI: 10.1002/art.1780340204.
  • Postoperative joint infections in rheumatoid arthritis patients on methotrexate therapy / M.T. Carpenter, S.G. West, S.A. Vogelgesang, D.E. Casey Jones // Orthopedics. 1996. Vol. 19, No 3. P. 207-210. DOI: 10.3928/0147-7447-19960301-09.
  • Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery / D.M. Grennan, J. Gray, J. Loudon, S. Fear // Ann. Rheum. Dis. 2001. Vol. 60, No 3. P. 214-217. DOI: 10.1136/ard.60.3.214.
  • BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies / T. Ding, J. Ledingham, R. Luqmani, S. Westlake, K. Hyrich, M. Lunt, P. Kiely, M. Bukhari, R. Abernethy, A. Bosworth, A. Ostor, K. Gadsby, F. McKenna, D. Finney, J. Dixey, C. Deighton; Standards, Audit and Guidelines Working Group of BSR Clinical Affairs Committee; BHPR // Rheumatology (Oxford). 2010. Vol. 49, No 11. P. 2217-2219. DOI: 10.1093/rheumatology/keq249a.
  • American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis / K.G. Saag, G.G. Teng, N.M. Patkar, J. Anuntiyo, C. Finney, J.R. Curtis, H.E. Paulus, A. Mudano, M. Pisu, M. Elkins-Melton, R. Outman, J.J. Allison, M. Suarez Almazor, S.L. Bridges Jr., W.W. Chatham, M. Hochberg, C. MacLean, T. Mikuls, L.W. Moreland, J. O'Dell, A.M. Turkiewicz, D.E. Furst; American College of Rheumatology // Arthritis Rheum. 2008. Vol. 59, No 6. P. 762-784. DOI: 10.1002/art.23721.
  • Mitigation and education/ V.K. Aggarwal, E.H. Tischler, C. Lautenbach, G.RWilliams Jr., J.AAbboud, M. Altena, T.L. Bradbury, J.H. Calhoun, D.A. Dennis, D.J. Del Gaizo, L. Font-Vizcarra, K. Huotari, S.L. Kates, K.H. Koo, T.M. Mabry, C.S. Moucha, J.C. Palacio, T.N. Peel, R.W. Poolman, W.J. Robb 3rd, R. Salvagno, T. Seyler, G. Skaliczki, E.M. Vasarhelyi, W.C. Watters // J. Arthroplasty. 2014. Vol. 29, No 2 Suppl. Р. 19-25. DOI: 10.1016/j.arth.2013.09.028.
  • Preoperative anemia in total joint arthroplasty: is it associated with periprosthetic joint infection? / M. Greenky, K. Gandhi, L. Pulido, C. Restrepo, J. Parvizi // Clin. Orthop. Relat. Res. 2012. Vol. 470, No 10. P. 2695-2701. DOI: 10.1007/s11999-012-2435-z.
  • Marik P.E. The hazards of blood transfusion // Br. J. Hosp. Med. (Lond). 2009. Vol. 70, No 1. P. 12-15. DOI: 10.12968/hmed.2009.70.1.37688.
  • Borghi B., Casati A. Incidence and risk factors for allogenic blood transfusion during major joint replacement using an integrated autotransfusion regimen. The Rizzoli Study Group on Orthopaedic Anaesthesia // Eur. J. Anaesthesiol. 2000. Vol. 17, No 7. P. 411-417. DOI: 10.1046/j.1365-2346.2000.00693.x.
  • Spahn D.R. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature // Anesthesiology. 2010. Vol. 113, No 2. P. 482-495. DOI: 10.1097/ALN.0b013e3181e08e97.
  • Myers E., O'Grady P., Dolan A.M. The influence of preclinical anaemia on outcome following total hip replacement // Arch. Orthop. Trauma Surg. 2004. Vol. 124, No 10. P. 699-701. DOI: 10.1007/s00402-004-0754-6.
  • Baek S.H. Identification and preoperative optimization of risk factors to prevent periprosthetic joint infection // World J. Orthop. 2014. Vol. 5, No 3. P. 362-367. DOI: 10.5312/wjo.v5.i3.362.
  • Pre-operative injections of epoetin-alpha versus post-operative retransfusion of autologous shed blood in total hip and knee replacement: a prospective randomised clinical trial / A.F. Moonen, B.J. Thomassen, N.T. Knoors, J.J. van Os, A.D. Verburg, P. Pilot // J. Bone Joint Surg. Br. 2008. Vol. 90, No 8. P. 1079-1083. DOI: 10.1302/0301-620X.90B8.20595.
  • Total knee arthroplasty in patients with liver cirrhosis / L.Y. Shih, C.Y. Cheng, C.H. Chang, K.Y. Hsu, R.W. Hsu, H.N. Shih // J. Bone Joint Surg. Am. 2004. Vol. 86, No 2. P. 335-341. DOI: 10.2106/00004623-200402000-00017.
  • Hepatitis B Virus Infection is a Risk Factor for Periprosthetic Joint Infection among Males after Total Knee Arthroplasty: A Taiwanese Nationwide Population-Based Study / S.J. Kuo, P.H. Huang, C.C. Chang, F.C. Kuo, C.T. Wu, H.C. Hsu, C.C. Lin // Medicine (Baltimore). 2016. Vol. 95, No 22. P. e3806. DOI: 10.1097/MD.0000000000003806.
  • Association of hepatitis B infection with high-risk complications in total joint arthroplasty / J. Wang, G. Zhao, J. Chen, J. Xia, S. Wang, G. Huang, F. Chen, J. Shi, Y. Yang, Y. Wei // BMC Musculoskelet. Disord. 2019. Vol. 20, No 1. P.163. DOI: 10.1186/s12891-019-2535-y.
  • Soluble CD163 from activated macrophages predicts mortality in acute liver failure / H.J. M0ller, H. Granbaek, F.V. Schi0dt, P. Holland-Fischer, M. Schilsky, S. Munoz, T. Hassanein, W.M. Lee; U.S. Acute Liver Failure Study Group // J. Hepatol. 2007. Vol. 47, No 5. P. 671-676. DOI: 10.1016/j. jhep.2007.05.014.
  • Changes in tumor necrosis factor-a and interleukin-1 beta production following liver surgery on cirrhotic patients / T. Sato, Y. Asanuma, Y. Masaki, Y. Sato, Y. Hatakeyama, T. Kusano, K. Koyama // Hepatogastroenterology. 1996. Vol. 43, No 11. P. 1148-1153.
  • Stress response to hepatectomy in patients with a healthy or a diseased liver / A. K. Lan, H.N. Luk, S. Goto, S.M. Chen, H.L. Eng, Y.S. Chen, V.H. de Villa, C.C. Wang, Y.F. Cheng, C.L. Chen, J.H. Lee, B. Jawan // World J. Surg. 2003. Vol. 27, No 7. P. 761-764. DOI: 10.1007/s00268-003-6955-2.
  • Cirrhosis patients have increased risk of complications after hip or knee arthroplasty / T. Deleuran, H. Vilstrup, S. Overgaard, P. Jepsen // Acta Orthop. 2015. Vol. 86, No 1. P. 108-113. DOI: 10.3109/17453674.2014.961397.
  • In-hospital surgical site infections after primary hip and knee arthroplasty - incidence and risk factors / L.A. Poultsides, Y. Ma, A.G. Della Valle, Y.L. Chiu, T.P. Sculco, S.G. Memtsoudis // J. Arthroplasty. 2013. Vol. 28, No 3. P. 385-389. DOI: 10.1016/j.arth.2012.06.027.
  • Prosthetic hip infection in patients with liver cirrhosis: an outcome analysis / P.H. Hsieh, S.W. Ueng, M.S. Lee, H.N. Shih, K.C. Huang // Int. J. Infect. Dis. 2010. Vol. 14, No 12. P. e1054-1059. DOI: 10.1016/j.ijid.2010.06.018.
  • Risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis / Y. Zhu, F. Zhang, W. Chen, S. Liu, Q. Zhang, Y. Zhang // J. Hosp. Infect. 2015. Vol. 89, No 2. Р. 82-89. DOI: 10.1016/j.jhin.2014.10.008.
  • Periprosthetic joint infection: the incidence, timing, and predisposing factors / L. Pulido, E. Ghanem, A. Joshi, J.J. Purtill, J. Parvizi // Clin. Orthop. Relat. Res. 2008. Vol. 466, No 7. P. 1710-1715. DOI: 10.1007/s11999-008-0209-4.
  • Perioperative hyperglycemia and postoperative infection after lower limb arthroplasty / B. Mraovic, D. Suh, C. Jacovides, J. Parvizi // J. Diabetes Sci. Technol. 2011. Vol. 5, No 2. P. 412-418. DOI: 10.1177/193229681100500231.
  • Patients with atrial fibrillation undergoing total joint arthroplasty increase hospital burden / V.K. Aggarwal, E.H. Tischler, Z.D. Post, I. Kane, F.R. Orozco, A. Ong // J. Bone Joint Surg. Am. 2013. Vol. 95, No 17. P. 1606-1611. DOI: 10.2106/JBJS.L.00882.
  • Добронравов В.А. Современный взгляд на патофизиологию вторичного гиперпаратиреоза. Роль фактора роста фибробластов 23 и KLOTHO // Нефрология. 2011. Т. 15, № 4. С. 11-20. doi: 10.24884/1561-6274-2011-15-4-11-20.
  • Tornero E., Riba J., Garcia-Ramiro S. Special issues involving periprosthetic infection in immunodeficiency patients // Open Orthop. J. 2013. Vol. 7. P. 211-218. DOI: 10.2174/1874325001307010211.
  • Review article: Total hip replacement in haemodialysis or renal transplant patients / D. Lieu, I.A. Harris, J.M. Naylor, R. Mittal // J. Orthop. Surg. (Hong Kong). 2014. Vol. 22, No 3. P. 393-398. DOI: 10.1177/230949901402200325.
  • Ford P.M. Arthropathies associated with renal disease including dialysis-related amyloid // Curr. Opin. Rheumatol. 1992. Vol. 4, No 1. P. 63-67.
  • Total hip arthroplasty in patients with renal failure: a comparison between transplant and dialysis patients / M.W. Shrader, D. Schall, J. Parvizi, J.T. McCarthy, D.G. Lewallen // J. Arthroplasty. 2006. Vol. 21, No 3. P. 324-329. DOI: 10.1016/j.arth.2005.07.008.
  • McCleery M.A., Leach W.J., Norwood T. Rates of infection and revision in patients with renal disease undergoing total knee replacement in Scotland // J. Bone Joint Surg. Br. 2010. Vol. 92, No 11. P.1535-1539. DOI: 10.1302/0301-620X.92B11.23870.
  • Nowicki P., Chaudhary H. Total hip replacement in renal transplant patients // J. Bone Joint Surg. Br. 2007. Vol. 89, No 12. P. 1561-1566. DOI: 10.130 2/0301-620X.89B12.19400.
  • Total hip replacement in renal transplant patients / S. Deo, C.L. Gibbons, M. Emerton, A.H. Simpson // J. Bone Joint Surg. Br. 1995. Vol. 77, No 2. P. 299-302.
  • Park C.H., Lee Y.K., Koo K.H. Lower Urinary Tract Infection and Periprosthetic Joint Infection after Elective Primary Total Hip Arthroplasty // Hip Pelvis. 2017. Vol. 29, No 1. P. 30-34. DOI: 10.5371/hp.2017.29.1.30.
  • Schmitt D.R., Schneider A.M., Brown N.M. Impact of Perioperative Urinary Tract Infection on Surgical Site Infection in Patients Undergoing Primary Hip and Knee Arthroplasty // J. Arthroplasty. 2020. Vol. 35, No 10. P. 2977-2982. DOI: 10.1016/j.arth.2020.05.025.
  • The Impact of Common Urologic Complications on the Risk of a Periprosthetic Joint Infection / N. Punjani, B. Lanting, J.A. McClure, J. Winick-Ng, B. Welk // J. Bone Joint Surg. Am. 2018. Vol. 100, No 17. P. 1517-1523. DOI: 10.2106/JBJS.17.01405.
  • Effect of urinary tract infection on the risk of prosthetic joint infection: A systematic review and meta-analysis / C. Wang, W. Huang, Y. Gu, J. Xiong, Z. Ye, D. Yin, X. Mu // Surgeon. 2021. Vol. 19, No 3. P. 175-182. DOI: 10.1016/j.surge.2020.04.010.
  • Parvizi J., Koo K.H. Should an urinary tract infection be treated before a total joint arthroplasty? // Hip Pelvis. 2019. Vol. 31, No 1. P. 1-3. DOI: 10.5371/hp.2019.31.1.1.
  • Human Immunodeficiency Virus Infection and Hip and Knee Arthroplasty / D. Dimitriou, M. Ramokgopa, J.R.T. Pietrzak, D. van der Jagt, L. Mokete // JBJS Rev. 2017. Vol. 5, No 9. P. e8. DOI: 10.2106/JBJS.RVW.17.00029.
  • Lin C.A., Kuo A.C., Takemoto S. Comorbidities and perioperative complications in HIV-positive patients undergoing primary total hip and knee arthroplasty // J. Bone Joint Surg. Am. 2013. Vol. 95, No 11. P. 1028-1036. DOI: 10.2106/JBJS.L.00269.
  • Total Hip Arthroplasty in Human Immunodeficiency Virus-Positive Patients: A Concise Follow-Up at 10 to 14 Years / D. Novikov, A.A. Anoushiravani, K.K. Chen, T.S. Wolfson, N. Snir, R. Schwarzkopf // J. Arthroplasty. 2019. Vol 34, No 3. P. 522-526. DOI: 10.1016/j.arth.2018.11.001.
  • Human Immunodeficiency Virus and Total Joint Arthroplasty: The Risk for Infection is Reduced / M.A. Enayatollahi, D. Murphy, M.G. Maltenfort, J. Parvizi // J. Arthroplasty. 2016. Vol. 31, No 10. P. 2146-2151. DOI: 10.1016/j.arth.2016.02.058.
  • Falakassa J., Diaz A., Schneiderbauer M. Outcomes of total joint arthroplasty in HIV patients // Iowa Orthop. J. 2014. Vol. 34. P. 102-106.
  • Leonard B.E. The immune system, depression and the action of antidepressants // Prog. Neuropsychopharmacol. Biol. Psychiatry. 2001. Vol. 25, No 4. P. 767-780. DOI: 10.1016/s0278-5846(01)00155-5.
  • Association between comorbid depression and osteoarthritis symptom severity in patients with knee osteoarthritis / K.W. Kim, J.W. Han, H.J. Cho, C.B. Chang, J.H. Park, J.J. Lee, S.B. Lee, S.C. Seong, T.K. Kim // J. Bone Joint Surg. Am. 2011. Vol. 93, No 6. P. 556-563. DOI: 10.2106/JBJS.I.01344.
  • Identification of high-risk groups for complication after arthroplasty: predictive value of patient's related risk factors / M.C. Castano-Betancourt, R.F. Annichino, M. de Azevedo E. Souza Munhoz, E.G. Machado, M.V. Lipay, E. Marchi // J. Orthop. Surg. Res. 2018. Vol. 13, No 1. P. 328. DOI: 10.1186/s13018-018-1036-2.
  • Материалы Второй международной согласительной конференции по скелетно-мышечной инфекции / пер. с англ.; под общ. ред. Р.М. Ти-хилова, С.А. Божковой, И.И. Шубнякова. СПб.: РНИИТО им. Р.Р. Вредена, 2019. 314 с.
  • Periprosthetic joint infection in patients with inflammatory joint disease: a review of risk factors and current approaches to diagnosis and management / T.A. Morrison, M. Figgie, A.O. Miller, S.M. Goodman // HSS J. 2013. Vol. 9, No 2. P. 183-194. DOI: 10.1007/s11420-013-9338-8.
  • Increased risk of complications following total joint arthroplasty in patients with rheumatoid arthritis / B. Ravi, R. Croxford, S. Hollands, J.M. Paterson, E. Bogoch, H. Kreder, G.A. Hawker // Arthritis Rheumatol. 2014. Vol. 66, No 2. P. 254-263. DOI: 10.1002/art.38231.
  • Cancienne J.M., Werner B.C., Browne J.A. Complications of primary total knee arthroplasty among patients with rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and osteoarthritis // J. Am. Acad. Orthop. Surg. 2016. Vol. 24, No 8. P. 567-574. DOI: 10.5435/JAAOS-D-15-00501.
  • Patients with a History of Treated Septic Arthritis are at High Risk of Periprosthetic Joint Infection after Total Joint Arthroplasty / A.A. Sultan, B. Mahmood, L.T. Samuel, J. George, M. Faour, C.E. Pelt, M.B. Anderson, A.K. Klika, C.A. Higuera // Clin. Orthop. Relat. Res. 2019. Vol. 477, No 7. P. 1605-1612. DOI: 10.1097/œRR.0000000000000688.
  • Periprosthetic Joint Infection in Patients with Inflammatory Joint Disease: Prevention and Diagnosis / A. Premkumar, K. Morse, A.E. Levack, M.P. Bostrom, A.V. Carli // Curr. Rheumatol. Rep. 2018. Vol. 20, No 11. P. 68. DOI: 10.1007/s11926-018-0777-6.
  • Prior hip or knee prosthetic joint infection in another joint increases risk three-fold of prosthetic joint infection after primary total knee arthroplasty: a matched control study / B.P. Chalmers, J.T. Weston, D.R. Osmon, A.D. Hanssen, D.J. Berry, M.P. Abdel // Bone Joint J. 2019. Vol. 101-B, No 7_ Supple_C. Р. 91-97. DOI: 10.1302/0301-620X.101B7.BJJ-2018-1189.R1.
  • A History of Treated Periprosthetic Joint Infection Increases the Risk of Subsequent Different Site Infection / H. Bedair, N. Goyal, M.J. Dietz, K. Urish, V. Hansen, J. Manrique, W. Hamilton, G. Deirmengian // Clin. Orthop. Relat. Res. 2015. Vol. 473, No 7. P. 2300-2304. DOI: 10.1007/ s11999-015-4174-4.
  • Особенности иммунного ответа у пациентов с ранними инфекционными осложнениями после эндопротезирования коленного и тазобедренного суставов / Н.А. Корж, В.А. Филиппенко, Ф.С. Леонтьева, А.П. Марущак, Н.В. Кузнецова, В.Ю. Делевская // Ортопедия, травматология и протезирование. 2018. № 4. С. 86-91.
  • Is hemoglobin A1c and perioperative hyperglycemia predictive of periprosthetic joint infection following total joint arthroplasty? A systematic review and meta-analysis / L. Yang, Y. Sun, G. Li, J. Liu // Medicine (Baltimore). 2017. Vol 96, No 51. P. e8805. DOI: 10.1097/MD.0000000000008805.
  • Inadequate Glycemic Control Is Associated With Increased Surgical Site Infection in Total Joint Arthroplasty: A Systematic Review and Meta-Analysis / N. Shohat, K. Muhsen, R. Gilat, A.J. Rondon, A.F. Chen, J. Parvizi // J. Arthroplasty. 2018. Vol. 33, No 7. P. 2312-2321. DOI: 10.1016/j. arth.2018.02.020.
  • Is Hemoglobin A1c or Perioperative Hyperglycemia Predictive of Periprosthetic Joint Infection or Death following Primary Total Joint Arthroplasty? / J. Chrastil, M.B. Anderson, V. Stevens, R. Anand, C.L. Peters, C.E. Pelt // J. Arthroplasty. 2015. Vol. 30, No 7. P. 1197-1202. DOI: 10.1016/j. arth.2015.01.040.
  • The Prevalence of Diabetes Mellitus and Routine Hemoglobin A1c Screening in Elective Total Joint Arthroplasty Patients / J.D. Capozzi, E.R. Lepkowsky, M.M. Callari, E.T. Jordan, J.A. Koenig, G.H. Sirounian // J. Arthroplasty. 2017. Vol. 32, No 1. P. 304-308. DOI: 10.1016/j. arth.2016.06.025.
  • Effect of preoperative hemoglobin A(1c) level on acute postoperative complications of total joint arthroplasty / D.T. Goldstein, J.B. Durinka, N. Martino, J.W. Shilling // Am. J. Orthop. (Belle Mead NJ). 2013. Vol. 42, No 10. P. E88-E90.
  • Do glycemic markers predict occurrence of complications after total knee arthroplasty in patients with diabetes? / J.S. Hwang, S.J. Kim, A.B. Bamne, Y.G. Na, T.K. Kim // Clin. Orthop. Relat. Res. 2015. Vol. 473, No 5. P.1726-1731. DOI: 10.1007/s11999-014-4056-1.
  • Many diabetic total joint arthroplasty candidates are unable to achieve a preoperative hemoglobin A1c goal of 7 % or less / N.J. Giori, L.S. Ellerbe, T. Bowe, S. Gupta, A.H. Harris // J. Bone Joint Surg. Am. 2014. Vol. 96, No 6. P. 500-504. DOI: 10.2106/JBJS.L.01631.
  • Cancienne J.M., Werner B.C., Browne J.A. Is there an association between Hemoglobin A1C and deep postoperative infection after TKA? // Clin. Orthop. Relat. Res. 2017. Vol. 475, No 6. P. 1642-1649. DOI: 10.1007/s11999-017-5246-4.
  • Prevention of Periprosthetic Joint Infection (PJI): A Clinical Practice Protocol in High-Risk Patients / F. Iannotti, P. Prati, A. Fidanza, R. Iorio, A. Ferretti, D.P. Prieto, N. Kort, B. Violante, G. Pipino, A.S. Panni, M. Hirschmann, M. Mugnaini, P.F. Indelli // Trop. Med. Infect. Dis. 2020. Vol. 5, No 4. P. 186. DOI: 10.3390/tropicalmed5040186.
  • Cancienne J.M., Werner B.C., Browne J.A. Is there a threshold value of Hemoglobin A1c that predicts risk of infection following primary total hip arthroplasty? // J. Arthroplasty. 2017. Vol. 32, No 9S. P. S236-S240. DOI: 10.1016/j.arth.2017.01.022.
  • Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection / R. Iorio, K.M. Williams, A.J. Marcantonio, L.M. Specht, J.F. Tilzey, W.L. Healy // J. Arthroplasty. 2012. Vol. 27, No 5. P. 726-729.e1. DOI: 10.1016/j.arth.2011.09.013.
  • Diabetes mellitus, hyperglycemia, hemoglobin A1C and the risk of prosthetic joint infections in total hip and knee arthroplasty / H.M. Kremers, L.W. Lewallen, T.M. Mabry, D.J. Berry, E.F. Berbari, D.R. Osmon // J. Arthroplasty. 2015. Vol. 30, No 3. P. 439-443. DOI: 10.1016/j.arth.2014.10.009.
  • Филиппенко В.А., Марущак А.П., Бондаренко С.Е. Перипротезная инфекция: диагностика и лечение. Часть 1 (Обзор литературы) // Ортопедия, травматология и протезирование. 2016. № 2. С. 102-110.
  • 2018 International Consensus Meeting on Musculoskeletal Infection: Research Priorities from the General Assembly Questions // E.M. Schwarz, J. Parvizi, T. Gehrke, A. Aiyer, A. Battenberg, S.A. Brown, J.J. Callaghan, M. Citak, K. Egol, G.E. Garrigues, M. Ghert, K. Goswami, A. Green, S. Hammound, S.L. Kates, A.C. McLaren, M.A. Mont, S. Namdari, W.T. Obremskey, R. O'Toole, S. Raikin, C. Restrepo, B. Ricciardi, K. Saeed, J. Sanchez-Sotelo, N. Shohat, T. Tan, C.P. Thirukumaran, B. Winters // J. Orthop. Res. 2019. Vol. 37, No 5. P. 997-1006. DOI: 10.1002/jor.24293.
  • Weale R., El-Bakri F., Saeed K. Pre-operative asymptomatic bacteriuria: a risk factor for prosthetic joint infection? // J. Hosp. Infect. 2019. Vol. 101, No 2. P. 210-213. DOI: 10.1016/j.jhin.2018.04.011.
  • Total knee arthroplasty in women with asymptomatic urinary tract infection / H. Singh, S. Thomas, S. Agarwal, S.C. Arya, S. Srivastav, N. Agarwal // J. Orthop. Surg. (Hong Kong). 2015. Vol. 23, No 3. P. 298-300. DOI: 10.1177/230949901502300307.
  • The Potential Value of Performing Preoperative Urinalysis prior to Total Knee Arthroplasty / D.J. Johnson, L.M. Hansen, H.E. Smith, M.A. Oyer, D.W. Manning // J. Arthroplasty. 2021. Vol. 36, No 1. P. 118-121. DOI: 10.1016/j.arth.2020.07.014.
  • 100.Is asymptomatic bacteriuria a risk factor for prosthetic joint infection? / R. Sousa, E. Munoz-Mahamud, J. Quayle, L.D. da Costa, C. Casals, P. Scott, P. Leite, P. Vilanova, S. Garcia, M.H. Ramos, J. Dias, A. Soriano, A. Guyot // Clin. Infect. Dis. 2014. Vol. 59, No 1. P. 41-47. DOI: 10.1093/ cid/ciu235.
  • 101.The necessity of treating asymptomatic bacteriuria with antibiotics in the perioperative period of joint arthroplasty: a metaanalysis / S.A. Jami, S.J. Dang, Z. Zhou, L. Changhao // Turk. J. Med. Sci. 2021. Vol. 51, No 2. P. 464-472. DOI: 10.3906/sag-2003-22.
  • 102.Current evidence does not support systematic antibiotherapy prior to joint arthroplasty in patients with asymptomatic bacteriuria - a meta analysis / C. Wang, D. Yin, W. Shi, W. Huang, D. Zuo, Q. Lu // Int. Orthop. 2018. Vol. 42, No 3. P. 479-485. DOI: 10.1007/s00264-018-3765-6.
  • 103.Mayne A.I.W., Davies P.S.E., Simpson J.M. Antibiotic treatment of asymptomatic bacteriuria prior to hip and knee arthroplasty; a systematic review of the literature // Surgeon. 2018. Vol. 16, No 3. P. 176-182. DOI: 10.1016/j.surge.2017.08.007.
  • 104.Is routine urinary screening indicated prior to elective total joint arthroplasty? A systematic review and meta-analysis / R.J.G. Sousa, M.A. Abreu, M. Wouthuyzen-Bakker, A.V. Soriano // J. Arthroplasty. 2019. Vol. 34, No 7. P. 1523-1530. DOI: 10.1016/j.arth.2019.03.034.
  • 105.Deep infection after total hip replacement: a method for national incidence surveillance / V. Lindgren, M. Gordon, P. Wretenberg, J. Kärrholm, G. Garellick // Infect. Control Hosp. Epidemiol. 2014. Vol. 35, No 12. P. 1491-1496. DOI: 10.1086/678600.
  • 106.Increasing risk of prosthetic joint infection after total hip arthroplasty / H. Dale, A.M. Fenstad, G. Hallan, L.I. Havelin, O. Furnes, S. Overgaard, A.B. Pedersen, J. Kärrholm, G. Garellick, P. Pulkkinen, A. Eskelinen, K. Mäkelä, L.B. Engesœter // Acta Orthop. 2012. Vol. 83, No 5. P. 449-458. DOI: 10.3109/17453674.2012.733918.
  • 107.Periprosthetic joint infection / B.H. Kapadia, R.A. Berg, J.A. Daley, J. Fritz, A. Bhave, M.A. Mont // Lancet. 2016. Vol. 387, No 10016. P. 386-394. DOI: 10.1016/S0140-6736(14)61798-0.
  • 108.Causative organisms in revision total hip & knee arthroplasty for infection: Increasing multi-antibiotic resistance in coagulase-negative Staphylococcus and the implications for antibiotic prophylaxis / A.M. Malhas, R. Lawton, M. Reidy, D. Nathwani, B.A. Clift // Surgeon. 2015. Vol. 13, No 5. Р. 250-255. DOI: 10.1016/j.surge.2014.04.002.
  • 109.Validation of reoperations due to infection in the Swedish Hip Arthroplasty Register // J.V. Lindgren, M. Gordon, P. Wretenberg, J. Kärrholm, G. Garellick // BMC Musculoskelet. Disord. 2014. Vol. 15. P. 384. DOI: 10.1186/1471-2474-15-384.
  • 110.The "true" incidence of surgically treated deep prosthetic joint infection after 32,896 primary total hip arthroplasties: a prospective cohort study / P.H. Gundtoft, S. Overgaard, H.C. Sch0nheyder, J.K. M0ller, P. Kj^rsgaard-Andersen, A.B. Pedersen // Acta Orthop. 2015. Vol. 86, No 3. P. 326334. DOI: 10.3109/17453674.2015.1011983.
  • Extended Oral Antibiotic Prophylaxis in High-Risk Patients Substantially Reduces Primary Total Hip and Knee Arthroplasty 90-Day Infection Rate / A. Inabathula, J.E. Dilley, M. Ziemba-Davis, L.C. Warth, K.A. Azzam, P.H. Ireland, R.M. Meneghini // J. Bone Joint Surg. Am. 2018. Vol. 100, No 24. P. 2103-2109. DOI: 10.2106/JBJS.17.01485.
  • 2019 John Charnley Award: Increased risk of prosthetic joint infection following primary total knee and hip arthroplasty with the use of alternative antibiotics to cefazolin: the value of allergy testing for antibiotic prophylaxis / C.C. Wyles, M. Hevesi, D.R. Osmon, M.A. Park, E.B. Habermann, D.G. Lewallen, D.J. Berry, R.J. Sierra // Bone Joint J. 2019. Vol. 101-B, No 6_Supple_B. Р. 9-15. DOI: 10.1302/0301-620X.101B6.BJJ-2018-1407.R1.
  • 113.Familial Clustering Identified in Periprosthetic Joint Infection following Primary Total Joint Arthroplasty: A Population-Based Cohort Study / M.B. Anderson, K. Curtin, J. Wong, C.E. Pelt, C.L. Peters, J.M. Gililland // J. Bone Joint Surg. Am. 2017. Vol. 99, No 11. P. 905-913. DOI: 10.2106/ JBJS.16.00514.
Еще
Статья обзорная
SciUp 2024 © 2024 ©